Stem Cell Patents Attacked Again
Stem Cell Patents Attacked Again
Two consumer advocacy groups in California have petitioned the US Patent and Trademark Office to revoke the stem cell patents held by the Wisconsin Alumni Research Foundation. According to an article in the San Jose Mercury News, the two groups believe the patents are driving researchers to other countries and may hurt the CIRM. Another article, from the Contra Costa Times and reprinted in the Kansas City Star, quoted one researcher as saying that the patents are impeding research. She said that she can get a license without difficulty but expects problems with any attempts to work with a biotech company to develop a treatment. The WARF is sticking to its claim that the patents do not interfere with research and in fact supports it (licensing fees from use of the patents are rolled back in to research dollars). The Mercury News articles has an assertion from one person that the patents should not have been granted in the first place because the same techniques had been used previously by others; a story about the issue on Science Now quotes Harvard researcher Doug Melton as saying that the WARF license are "onerous, restrictive, and uncooperative.”
One of the issues that’s coming up is if a technique can be considered obvious and therefore unpatentable if it works in one species of animal but not another. Does the ability to clone a dog mean that cloning a human is now considered “prior art”? This is a pretty important issue for biotechnology, and I’ll be unsurprised if it winds up in court. There are some fundamental research issues at stake here.
